Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.
Identifieur interne : 000E17 ( PubMed/Curation ); précédent : 000E16; suivant : 000E18Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.
Auteurs : C. Monaca [France] ; A. Duhamel ; J M Jacquesson ; C. Ozsancak ; A. Destée ; J D Guieu ; L. Defebvre ; P. DerambureSource :
- Sleep medicine [ 1389-9457 ] ; 2006.
English descriptors
- KwdEn :
- Aged, Arousal (drug effects), Arousal (physiology), Disorders of Excessive Somnolence (epidemiology), Disorders of Excessive Somnolence (physiopathology), Dopamine Agents (adverse effects), Female, Humans, Male, Middle Aged, Parkinson Disease (physiopathology), Polysomnography, Prospective Studies, Sleep Apnea Syndromes, Surveys and Questionnaires.
- MESH :
- chemical , adverse effects : Dopamine Agents.
- drug effects : Arousal.
- epidemiology : Disorders of Excessive Somnolence.
- physiology : Arousal.
- physiopathology : Disorders of Excessive Somnolence, Parkinson Disease.
- Aged, Female, Humans, Male, Middle Aged, Polysomnography, Prospective Studies, Sleep Apnea Syndromes, Surveys and Questionnaires.
Abstract
To assess the prevalence of vigilance disorders in Parkinson's disease patients, relate the observed phenomena to potential causes and confirm these troubles with polysomnographic analysis.
DOI: 10.1016/j.sleep.2005.12.002
PubMed: 16740409
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E57
Links to Exploration step
pubmed:16740409Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.</title>
<author><name sortKey="Monaca, C" sort="Monaca, C" uniqKey="Monaca C" first="C" last="Monaca">C. Monaca</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Neurophysiologie Clinique, EA2683, Hôpital R. Salengro, CHRU de Lille, F-59037 Lille Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurophysiologie Clinique, EA2683, Hôpital R. Salengro, CHRU de Lille, F-59037 Lille Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Duhamel, A" sort="Duhamel, A" uniqKey="Duhamel A" first="A" last="Duhamel">A. Duhamel</name>
</author>
<author><name sortKey="Jacquesson, J M" sort="Jacquesson, J M" uniqKey="Jacquesson J" first="J M" last="Jacquesson">J M Jacquesson</name>
</author>
<author><name sortKey="Ozsancak, C" sort="Ozsancak, C" uniqKey="Ozsancak C" first="C" last="Ozsancak">C. Ozsancak</name>
</author>
<author><name sortKey="Destee, A" sort="Destee, A" uniqKey="Destee A" first="A" last="Destée">A. Destée</name>
</author>
<author><name sortKey="Guieu, J D" sort="Guieu, J D" uniqKey="Guieu J" first="J D" last="Guieu">J D Guieu</name>
</author>
<author><name sortKey="Defebvre, L" sort="Defebvre, L" uniqKey="Defebvre L" first="L" last="Defebvre">L. Defebvre</name>
</author>
<author><name sortKey="Derambure, P" sort="Derambure, P" uniqKey="Derambure P" first="P" last="Derambure">P. Derambure</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16740409</idno>
<idno type="pmid">16740409</idno>
<idno type="doi">10.1016/j.sleep.2005.12.002</idno>
<idno type="wicri:Area/PubMed/Corpus">000E57</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E57</idno>
<idno type="wicri:Area/PubMed/Curation">000E17</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E17</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.</title>
<author><name sortKey="Monaca, C" sort="Monaca, C" uniqKey="Monaca C" first="C" last="Monaca">C. Monaca</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Neurophysiologie Clinique, EA2683, Hôpital R. Salengro, CHRU de Lille, F-59037 Lille Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurophysiologie Clinique, EA2683, Hôpital R. Salengro, CHRU de Lille, F-59037 Lille Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Duhamel, A" sort="Duhamel, A" uniqKey="Duhamel A" first="A" last="Duhamel">A. Duhamel</name>
</author>
<author><name sortKey="Jacquesson, J M" sort="Jacquesson, J M" uniqKey="Jacquesson J" first="J M" last="Jacquesson">J M Jacquesson</name>
</author>
<author><name sortKey="Ozsancak, C" sort="Ozsancak, C" uniqKey="Ozsancak C" first="C" last="Ozsancak">C. Ozsancak</name>
</author>
<author><name sortKey="Destee, A" sort="Destee, A" uniqKey="Destee A" first="A" last="Destée">A. Destée</name>
</author>
<author><name sortKey="Guieu, J D" sort="Guieu, J D" uniqKey="Guieu J" first="J D" last="Guieu">J D Guieu</name>
</author>
<author><name sortKey="Defebvre, L" sort="Defebvre, L" uniqKey="Defebvre L" first="L" last="Defebvre">L. Defebvre</name>
</author>
<author><name sortKey="Derambure, P" sort="Derambure, P" uniqKey="Derambure P" first="P" last="Derambure">P. Derambure</name>
</author>
</analytic>
<series><title level="j">Sleep medicine</title>
<idno type="ISSN">1389-9457</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Arousal (drug effects)</term>
<term>Arousal (physiology)</term>
<term>Disorders of Excessive Somnolence (epidemiology)</term>
<term>Disorders of Excessive Somnolence (physiopathology)</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Polysomnography</term>
<term>Prospective Studies</term>
<term>Sleep Apnea Syndromes</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Arousal</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Arousal</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polysomnography</term>
<term>Prospective Studies</term>
<term>Sleep Apnea Syndromes</term>
<term>Surveys and Questionnaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the prevalence of vigilance disorders in Parkinson's disease patients, relate the observed phenomena to potential causes and confirm these troubles with polysomnographic analysis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16740409</PMID>
<DateCreated><Year>2006</Year>
<Month>07</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted><Year>2006</Year>
<Month>12</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1389-9457</ISSN>
<JournalIssue CitedMedium="Print"><Volume>7</Volume>
<Issue>5</Issue>
<PubDate><Year>2006</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Sleep medicine</Title>
<ISOAbbreviation>Sleep Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.</ArticleTitle>
<Pagination><MedlinePgn>448-53</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">To assess the prevalence of vigilance disorders in Parkinson's disease patients, relate the observed phenomena to potential causes and confirm these troubles with polysomnographic analysis.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A questionnaire was used to gather information on demographic data, previous and current treatments, disease characteristics, sleep and vigilance troubles. Somnolence was measured using the Epworth Sleepiness Scale (ESS). Nocturnal polysomnography (PSG) and multiple sleep latency tests (MSLT) were performed for a sample of parkinsonian patients.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred twenty-two parkinsonian patients completed the questionnaire, and 36 patients had objective analyses. Of the patients, 43.2% had an ESS score >10, and 28.4% reported somnolence in the hour after taking dopaminergic drugs, whereas 6.8% reported unintended sleep episodes. In view of questionnaire data, these vigilance disorders may be partly explained not only by the impact of nocturnal sleep disorders (e.g. sleep apnea syndromes) but also by dopaminergic therapy (especially with dopaminergic agonists). With PSG and MSLT results, we have shown a significant correlation between mean sleep latency and ESS score. Patients with unintended sleep episodes have severe sleepiness in MSLT compared with others patients.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vigilance disorders are frequently observed in Parkinson's disease. We recommend informing patients of the risk of occurrence of such conditions, notably for patients with unintended sleep episodes and with sleepiness in the hour after taking dopaminergic drugs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monaca</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Service de Neurophysiologie Clinique, EA2683, Hôpital R. Salengro, CHRU de Lille, F-59037 Lille Cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Duhamel</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jacquesson</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ozsancak</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Destée</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Guieu</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Defebvre</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Derambure</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>06</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Sleep Med</MedlineTA>
<NlmUniqueID>100898759</NlmUniqueID>
<ISSNLinking>1389-9457</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001143" MajorTopicYN="N">Arousal</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006970" MajorTopicYN="N">Disorders of Excessive Somnolence</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012891" MajorTopicYN="N">Sleep Apnea Syndromes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>06</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>11</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>12</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16740409</ArticleId>
<ArticleId IdType="pii">S1389-9457(05)00311-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.sleep.2005.12.002</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000E17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:16740409 |texte= Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16740409" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |